Latest news
Olomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer - CancerNetworkCancerNetwork · Tue, 04 Aug 2026 15:38:44 GMTCombining KRAS Inhibitors With PI3K and Checkpoint Blockade to Improve Response Durability - CancerNetworkCancerNetwork · Sat, 01 Aug 2026 16:03:25 GMTHow KRAS-Targeted Therapy May Advance Toward Cancer Prevention - CancerNetworkCancerNetwork · Thu, 30 Jul 2026 18:02:21 GMT